CHEN-HUA LIUYIH-SHARNG CHENSHOEI-SHEN WANGCHUN-JEN LIUTUNG-HUNG SUHUNG-CHIH YANGCHUN-MING HONGPEI-JER CHENDING-SHINN CHENJIA-HORNG KAO2019-11-272019-11-2720181058-4838https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040562078&doi=10.1093%2fcid%2fcix787&partnerID=40&md5=eb0e0d937ad36cc101d062c983dbc921https://scholars.lib.ntu.edu.tw/handle/123456789/433953We assessed the effectiveness and safety of sofosbuvir (SOF) combined with ledipasvir (LDV) or daclatasvir (DCV) in 12 heart transplant recipients with chronic hepatitis C virus (HCV). The sustained virologic response (SVR 12) rate was 100% [95% confidence interval [CI]: 75.8%-100%]. All patients tolerated treatment well without interruption, death, or serious adverse events. ? The Author(s) 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.[SDGs]SDG3alanine aminotransferase; cyclosporine; daclatasvir; everolimus; ledipasvir plus sofosbuvir; mycophenolate mofetil; prednisone; rapamycin; sofosbuvir; tacrolimus; virus RNA; antivirus agent; benzimidazole derivative; BMS-790052; fluorene derivative; imidazole derivative; ledipasvir; sofosbuvir; adult; alanine aminotransferase blood level; anemia; Article; chronic hepatitis C; clinical article; clinical assessment; confidence interval; drug dose titration; drug efficacy; drug safety; drug tolerability; duodenal ulcer bleeding; endoscopic therapy; female; graft recipient; heart transplantation; human; male; middle aged; priority journal; sustained virologic response; treatment outcome; adverse drug reaction; adverse event; chronic hepatitis C; combination drug therapy; pathology; procedures; prospective study; young adult; Adult; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fluorenes; Heart Transplantation; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Sofosbuvir; Sustained Virologic Response; Transplant Recipients; Treatment Outcome; Young Adultjournal article10.1093/cid/cix787290203592-s2.0-85040562078